Uscom Past Earnings Performance

Past criteria checks 0/6

Uscom's earnings have been declining at an average annual rate of -14.5%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been declining at an average rate of 7.7% per year.

Key information

-14.5%

Earnings growth rate

-7.2%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate-7.7%
Return on equity-67.8%
Net Margin-55.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Uscom Limited (ASX:UCM) Insiders Increased Their Holdings

Jan 25
Uscom Limited (ASX:UCM) Insiders Increased Their Holdings

Key Things To Understand About Uscom's (ASX:UCM) CEO Pay Cheque

Dec 01
Key Things To Understand About Uscom's (ASX:UCM) CEO Pay Cheque

Revenue & Expenses Breakdown

How Uscom makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:UCM Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244-250
31 Mar 244-250
31 Dec 233-250
30 Sep 233-250
30 Jun 233-350
31 Mar 232-350
31 Dec 222-250
30 Sep 222-250
30 Jun 223-250
31 Mar 223-250
31 Dec 213-250
30 Sep 213-150
30 Jun 214-150
31 Mar 215-150
31 Dec 206050
30 Sep 205-150
30 Jun 204-150
31 Mar 204-250
31 Dec 193-250
30 Sep 193-250
30 Jun 194-140
31 Mar 193-240
31 Dec 183-240
30 Sep 183-240
30 Jun 183-240
31 Mar 183-240
31 Dec 173-240
30 Sep 173-240
30 Jun 173-250
31 Mar 173-250
31 Dec 163-250
30 Sep 163-240
30 Jun 163-240
31 Mar 163-240
31 Dec 152-240
30 Sep 152-130
30 Jun 152-130
31 Mar 152-130
31 Dec 142-130
30 Sep 142-130
30 Jun 141-220
31 Mar 141-120

Quality Earnings: UCM is currently unprofitable.

Growing Profit Margin: UCM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: UCM is unprofitable, and losses have increased over the past 5 years at a rate of 14.5% per year.

Accelerating Growth: Unable to compare UCM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: UCM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).


Return on Equity

High ROE: UCM has a negative Return on Equity (-67.78%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 06:34
End of Day Share Price 2024/11/26 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Uscom Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution